Title |
Options in Prophylactic Surgery to Prevent Ovarian Cancer in High-Risk Women: How New Hypotheses of Fallopian Tube Origin Influence Recommendations
|
---|---|
Published in |
Current Treatment Options in Oncology, March 2016
|
DOI | 10.1007/s11864-016-0396-2 |
Pubmed ID | |
Authors |
Casey L. Swanson, Jamie N. Bakkum-Gamez |
Abstract |
In women at increased risk of developing ovarian cancer, risk-reducing salpingo-oophorectomy is the only intervention that has been shown to decrease mortality from ovarian cancer and is the standard of care for risk reduction. Prophylactic salpingectomy with delayed oophorectomy should be considered in high-risk premenopausal women in the setting of a clinical trial. |
X Demographics
The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 8 | 50% |
Canada | 1 | 6% |
Unknown | 7 | 44% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 14 | 88% |
Scientists | 2 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 3% |
India | 1 | 3% |
Unknown | 38 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 9 | 23% |
Student > Postgraduate | 5 | 13% |
Student > Doctoral Student | 3 | 8% |
Other | 3 | 8% |
Student > Master | 3 | 8% |
Other | 7 | 18% |
Unknown | 10 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 14 | 35% |
Nursing and Health Professions | 4 | 10% |
Biochemistry, Genetics and Molecular Biology | 2 | 5% |
Agricultural and Biological Sciences | 1 | 3% |
Social Sciences | 1 | 3% |
Other | 1 | 3% |
Unknown | 17 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 April 2016.
All research outputs
#3,199,821
of 22,858,915 outputs
Outputs from Current Treatment Options in Oncology
#57
of 662 outputs
Outputs of similar age
#54,431
of 301,001 outputs
Outputs of similar age from Current Treatment Options in Oncology
#1
of 16 outputs
Altmetric has tracked 22,858,915 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 662 research outputs from this source. They receive a mean Attention Score of 3.2. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 301,001 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.